ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CYTO Company Profile and Key Details

NASDAQ : CYTO

Altamira Therapeutics Ltd.

$0.30

At Close 4:00 PM

Not Actively Trading

62.82

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CYTO Stock Price Chart

Stock Price Today

Altamira Therapeutics Ltd. (CYTO) stock remained unchanged at $0.30 a share on NASDAQ. The stock opened at $0.42, fluctuating between $0.30 to $0.42 during the session.

Stock Snapshot

0.3

Prev. Close

0.42

Open

1.13M

Market Cap

3.78M

Number of Shares

0.3

Day Low

0.4158

Day High

0.16483516483516483

P/E Ratio

70.25%

Free Float in %

1.82

EPS (TTM)

30.76

Book Value

-44.13

Cash Flow per Share

724.3K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 11, 2025	0.13	0.16	0.13	0.13	1.76K
Feb 07, 2025	0.11	0.16	0.10	0.10	63.03K
Feb 05, 2025	0.14	0.17	0.11	0.11	20.25K
Feb 03, 2025	0.10	0.11	0.10	0.11	93.72K
Jan 31, 2025	0.11	0.12	0.11	0.11	14.75K
Jan 30, 2025	0.12	0.12	0.11	0.11	22.7K
Jan 29, 2025	0.13	0.15	0.11	0.12	26.78K
Jan 28, 2025	0.11	0.14	0.11	0.14	461
Jan 27, 2025	0.16	0.19	0.16	0.19	764
Jan 24, 2025	0.15	0.15	0.11	0.12	4.88K
Jan 23, 2025	0.11	0.16	0.11	0.16	7.48K
Jan 22, 2025	0.11	0.14	0.11	0.14	48.36K
Jan 21, 2025	0.15	0.17	0.11	0.17	66.84K
Jan 17, 2025	0.10	0.14	0.10	0.13	5.07K
Jan 16, 2025	0.10	0.15	0.10	0.11	724.3K
Jan 15, 2025	0.12	0.16	0.10	0.11	74.49K
Jan 14, 2025	0.17	0.17	0.12	0.13	4.42K
Jan 13, 2025	0.14	0.18	0.14	0.18	13.42K
Jan 10, 2025	0.18	0.19	0.12	0.17	33.12K
Jan 08, 2025	0.17	0.18	0.16	0.16	2.29K

Contact Details

Hamilton, HM 11

Bermuda

Website: https://altamiratherapeutics.comContact: 441 295 5950

About Company

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, which is in phase III clinical trial for the treatment of acute inner ear tinnitus; and Sonsuvi that is in phase III of clinical development for the treatment of acute inner ear hearing loss. It operates in Switzerland, the United States, Europe, and Australia. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda.

Frequently Asked Questions

What is the current Altamira Therapeutics Ltd. (CYTO) stock price?

Altamira Therapeutics Ltd. (NASDAQ: CYTO) stock price is $0.30 in the last trading session. During the trading session, CYTO stock reached the peak price of $0.42 while $0.30 was the lowest point it dropped to. The percentage change in CYTO stock occurred in the recent session was 0% while the dollar amount for the price change in CYTO stock was -.

CYTO's industry and sector of operation?

The NASDAQ listed CYTO is part of Biotechnology industry that operates in the broader Healthcare sector. Altamira Therapeutics Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CYTO?

Mr. Marcel Gremaud CPA
Chief Financial Officer
Dr. Covadonga Paneda
Chief Operating Officer
Dr. Thomas Meyer Ph.D.
Founder, Chairman, Chief Executive Officer & MD
Dr. Samuel A. Wickline M.D.
Chief Scientific Adviser
Mr. Marcel Gremaud C.P.A.
Chief Financial Officer
Mr. Jean Lechance
Unit Head of OTC Consumer Health Bus.
Dr. Covadonga Pañeda
Chief Devel. Officer

How CYTO did perform over past 52-week?

CYTO's closing price is 328.57% higher than its 52-week low of $0.07 where as its distance from 52-week high of $3.49 is -91.4%.

How many employees does CYTO have?

Number of CYTO employees currently stands at 10.

Link for CYTO official website?

Official Website of CYTO is: https://altamiratherapeutics.com

How do I contact CYTO?

CYTO could be contacted at phone 441 295 5950 and can also be accessed through its website. CYTO operates from Clarendon House, Hamilton, HM 11, Bermuda.

How many shares of CYTO are traded daily?

CYTO stock volume for the day was 724.3K shares. The average number of CYTO shares traded daily for last 3 months was 141.05K.

What is the market cap of CYTO currently?

The market value of CYTO currently stands at $1.13M with its latest stock price at $0.30 and 3.78M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	10
Beta	2.44
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology